Loading stock data…
$10.81-0.02 (-0.18%)
Translational Development Acquisition Corp.
Translational Development Acquisition Corp. in the Financial Services sector is trading at $10.81 with a market capitalization of $209M. The stock is currently 1% below its 52-week high of $10.95, remaining 1.2% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the safe zone. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$661,050↓ | -$281,161↓ | -$162,345↑ | -$213,658↑ | -$221,127 |
| Net Income | $946,982↓ | $1.33M↓ | $1.60M↓ | $1.66M↑ | $1.62M |
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or mor...